Business Wire

IN-IAC

2.5.2024 20:01:27 CEST | Business Wire | Press release

Share
The Indy Autonomous Challenge Returns to the Indianapolis Motor Speedway on September 6, 2024

The Indy Autonomous Challenge (IAC) will make a grand return to the Indianapolis Motor Speedway (IMS) “The Racing Capital of the World” on September 6th, 2024. The competition is set to be a landmark event, featuring a head-to-head race of the world’s fastest autonomous racecars piloted by AI driver software developed by 10 teams representing 18 top universities from North America, Europe, and Asia.

History was made at IMS in October 2021 when IAC organized the world’s first head-to-head high-speed autonomous racing competition. Since then, IAC has organized five races at iconic tracks, including Las Vegas Motor Speedway during CES and the Monza F1 Circuit in Italy. IAC and its university teams have achieved a long list of world records for high-speed ground-based autonomy. World records include the autonomous land speed record (192.2 mph), the top speed on-track (180 mph), the fastest on-track head-to-head overtake (177 mph), and most miles of autonomous racing (7,500 miles).

“Three years ago, we gathered the best and brightest minds from universities around the world to make history at Indianapolis Motor Speedway, proving that autonomous racing is possible and launching a global effort to accelerate the pursuit of high-speed autonomous mobility,” said Paul Mitchell, President of the Indy Autonomous Challenge. “After setting many records and proving that autonomous vehicles can race at extreme speeds, we are returning home to the Racing Capital of the World to attempt an even more ambitious head-to-head race.”

The upcoming race at IMS, which is being held in partnership with the Indiana Economic Development Corporation (IEDC), will be a high-adrenaline head-to-head race of multiple IAC AV-24 autonomous racecars. Teams from leading research universities worldwide will push the limits of autonomous technology, competing at breathtaking speeds on the iconic oval track. This race promises not just to entertain but to offer a glimpse into the future of mobility, where AI drivers can operate autonomous vehicles safely on highways at high speeds, reducing the risk of accidents and speeding up supply chain logistics.

“Indiana is a leader in the future of mobility, attracting new business investment, fostering R&D and inspiring innovation across EV, hydrogen and autonomy,” said Indiana Secretary of Commerce David Rosenberg. “The technologies, companies and talent being assembled by the Indy Autonomous Challenge are making significant strides in developing autonomous capabilities, putting Indiana at the forefront of tomorrow’s global economy while inspiring the next generation of leaders and risktakers.”

With 10 teams representing 18 universities from five countries, the race will be the world’s largest autonomous racing competition.

  • AI Racing Tech - University of California, Berkeley (California), with University of Hawai'i (Hawai’i), University of California, San Diego (California), and Carnegie Mellon University
  • Autonomous Tiger Racing - Auburn University (Alabama)
  • Black & Gold Autonomous Racing - Purdue University (Indiana)
  • Cavalier Autonomous Racing - University of Virginia (Virginia)
  • KAIST - Korea Advanced Institute of Science and Technology (South Korea)
  • Luddy Autonomous Racing – Indiana University (Indiana)
  • MIT-PITT-RW - Massachusetts Institute of Technology (Massachusetts), University of Pittsburgh (Pennsylvania), Rochester Institute of Technology (New York), and University of Waterloo (Canada)
  • PoliMOVE-MSU - Politecnico di Milano (Italy), Michigan State University (Michigan), University of Alabama (Alabama)
  • TUM Autonomous Motorsport - Technische Universität München (Germany)
  • UNIMORE Racing - University of Modena and Reggio Emilia (Italy)

“The Indianapolis Motor Speedway was originally built as a test bed for early automobiles,” said J. Douglas Boles, President of IMS. “Having teams from the world’s most elite research universities using the track to prove out the future of autonomous vehicles connects the track’s historic roots to the future of AI and robotics.”

The race will attract thousands of attendees from government, industry, and academia including 2,000 high school students studying Science, Technology, Engineering, and Math (STEM). The race event will be live-streamed worldwide for those who cannot attend in person.

“For many Hoosiers, your first trip to the Indianapolis Motor Speedway is a rite of passage,” said Indiana Secretary of Education Katie Jenner. “The Indy Autonomous Challenge provides a unique opportunity for students to visit the track and experience first-hand the incredible STEM technologies being developed right here in Indiana. We are excited to help recruit high school students to attend the event and partner in the planning of a STEM Zone that will connect them directly to future college and career opportunities.”

In addition to the “main event” head-to-head race, the day will include several interactive events and activations that will offer attendees a chance to learn about and engage with technologies of the future including autonomous vehicles, drones, robots, augmented and virtual reality, generative AI, sensor fusion, internet of things, etc. Activations will include:

  • Innovation Paddock: Interactive hard-tech exhibits by industry-leading companies, start-ups, universities, and innovation-based non-profits will be located in the Trackside Garages adjacent to the track. Here, attendees can interact with the latest technology advancements in mobility, AI, automation, robotics, and more.
  • Future Mobility Summit: An invitation-only summit centered around breakthrough advancements such as AI-driven autonomy, next-generation drones, smart infrastructure, and sustainable energy solutions, with a special focus on Indiana’s innovative contributions, the summit promises an unparalleled convergence of thought leaders from industry, government, and academia. This curated event, designed to spark meaningful discussions and foster policy development to accelerate the advent of future mobility, will feature dynamic keynotes and panel sessions steered by renowned figures from leading industry circles.
  • STEM Zone: Created in partnership with the Indiana Department of Education and dedicated to inspiring the next generation of innovators, the STEM Zone will engage students with interactive exhibits and educational sessions focused on science, technology, engineering, and mathematics underscoring the IAC's commitment to fostering curiosity and passion for STEM among youth, highlighting the critical role of education in the future of technology. Students will also have access to Innovation Paddock exhibitions, sponsored lunch concessions, and seating in the Tower Terrace Grandstands to watch the IAC race.

Companies, governments, universities, and non-profits interested in participating in the Indy Autonomous Challenge at IMS can contact info@indyautonomouschallenge.com. High School administrators or teachers interested in bringing students to the event can contact EEL@doe.in.gov. General attendees who would like to attend the race event can purchase tickets on the Indianapolis Motor Speedway website starting May 2nd, 2024.

About the IAC: The Indy Autonomous Challenge (IAC) is a non-profit corporation based in Indianapolis, Indiana (USA) which organizes racing competitions among university-affiliated teams representing 18 universities from around the world. Teams program AI drivers to pilot fully autonomous IAC racecars and compete in a series of history-making events at iconic tracks. Based in Indiana, the IAC is working to establish a hub for performance automation in the state and is harnessing the power of innovative competitions to attract the best and the brightest minds from around the globe to further state-of-the-art technology in safety and performance of automated vehicles. The IAC started as a $1 million prize competition with 31 university teams signing up to compete more than three years ago, representing top engineering and technology programs from 15 U.S. states and 11 countries. Follow the IAC @IndyAChallenge on LinkedIn, Twitter, Instagram, Facebook, & YouTube.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240502559440/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye